Logos Global Management »

Elevation Oncology shares owned by Logos Global Management

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $10M 3.9M 2.70
2024-03-31 $5.1M 1.0M 5.13

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Elevation Oncology

Logos Global Management
Farallon Capital Management
Tang Capital Management
Frazier Life Sciences Management
Aisling Capital Management
BlackRock
Balyasny Asset Management
Braidwell
venBio Partners
Hudson Bay Capital Management
BVF
Vanguard Group
Darwin Global Management
Palo Alto Investors
Point72 Asset Management

View all funds holding Elevation Oncology